(Q35721863)

9 August 2017

1 reference

title

Selective estrogen receptor modulation: concept and consequences in cancer (English)

1 reference

9 August 2017

1 reference

1

V Craig Jordan

1 reference

9 August 2017

publication date

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

5

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

207-213

1 reference

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Oestrogen receptors - an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Tamoxifen: a most unlikely pioneering medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Effects of anti-estrogens on bone in castrated and intact female rats

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Apoptotic Action of 17 -Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Connections and regulation of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Design and methods of the Raloxifene Use for The Heart (RUTH) study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Paradoxical Action of Fulvestrant in Estradiol-Induced Regression of Tamoxifen-Stimulated Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Structural insights into the mode of action of a pure antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Molecular determinants for the tissue specificity of SERMs

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900059-5

7 January 2021

10.1016/S1535-6108(04)00059-5

Identifiers

DOI

1 reference

9 August 2017

1 reference